We are live on ! Find out more
CODX

Co-Diagnostics

37 hedge funds and large institutions have $4.29M invested in Co-Diagnostics in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

3% more funds holding

Funds holding: 3637 (+1)

0.14% more ownership

Funds ownership: 0.46%0.6% (+0.14%)

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

22% less capital invested

Capital invested by funds: $5.52M → $4.29M (-$1.23M)

68% less call options, than puts

Call options by funds: $97K | Put options by funds: $299K

Holders
37
Holders Change
+1
Holders Change %
+2.78%
% of All Funds
0.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
8
Reduced
9
Closed
5
Calls
$97K
Puts
$299K
Net Calls
-$202K
Net Calls Change
-$279K

CODX Hedge Fund Activity: Q4 2024 in Review

37 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q4 2024, worth a combined $4.29M — down 22% from $5.52M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CODX positions and 5 closed out — a net gain of 2 holders — while 8 added to existing stakes and 9 trimmed.

The largest buyer was Private Advisory Group, opening a new position worth an estimated $1.24M. The largest seller was Jane Street, cutting an estimated $19.1K.

  • 37 institutional investors held Co-Diagnostics (CODX) as of Q4 2024, up from 36 in Q3 2024.
  • Funds reported $4.29M of Co-Diagnostics stock for Q4 2024, down 22% quarter-over-quarter.
  • 7 funds opened new Co-Diagnostics positions in Q4 2024 and 5 closed out, a net change of +2 holders.
  • The largest Co-Diagnostics buyer in Q4 2024 was Private Advisory Group, an estimated $1.24M added.
  • The largest Co-Diagnostics seller in Q4 2024 was Jane Street, an estimated $19.1K sold.

Based on aggregated 13F filings for Q4 2024.